Journal of Infection

Papers
(The H4-Index of Journal of Infection is 82. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The pathogenesis and treatment of the `Cytokine Storm' in COVID-191957
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis1502
Co-infections in people with COVID-19: a systematic review and meta-analysis1035
Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients970
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up788
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19732
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis682
The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2559
Clinical progression of patients with COVID-19 in Shanghai, China548
SARS-CoV-2 detection, viral load and infectivity over the course of an infection540
Saliva is a reliable tool to detect SARS-CoV-2513
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19506
Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study434
COVID-19 spike-host cell receptor GRP78 binding site prediction364
Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries356
Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study337
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact318
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19283
Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children269
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation263
Serological immunochromatographic approach in diagnosis with SARS-CoV-2 infected COVID-19 patients246
Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patient238
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis226
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China225
Emergence of a new SARS-CoV-2 variant in the UK212
Severe air pollution links to higher mortality in COVID-19 patients: The “double-hit” hypothesis.202
CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan, China200
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva199
Current epidemiological and clinical features of COVID-19; a global perspective from China193
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?179
Evolutionary analysis of SARS-CoV-2: how mutation of Non-Structural Protein 6 (NSP6) could affect viral autophagy177
Profile of specific antibodies to SARS-CoV-2: The first report175
Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19170
SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes169
Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis168
A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study166
High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients165
Environmental contamination of SARS-CoV-2 in healthcare premises164
Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies150
Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19149
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients145
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review145
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients136
Interleukin-6 as prognosticator in patients with COVID-19136
The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination135
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study134
Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2134
First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics132
Household transmission of SARS-CoV-2128
Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission128
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure127
Viral dynamics of SARS-CoV-2 in saliva from infected patients124
Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysis122
Risk factors associated with disease severity and length of hospital stay in COVID-19 patients121
Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK116
The duration of infectiousness of individuals infected with SARS-CoV-2111
Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis111
Regional air pollution persistence links to COVID-19 infection zoning110
Transmission of monkeypox virus through sexual contact – A novel route of infection110
Breast milk microbiota: A review of the factors that influence composition109
SARS-CoV-2 (COVID-19) superspreader events107
A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis107
Household transmission of COVID-19-a systematic review and meta-analysis107
Monkeypox outbreak in Madrid (Spain): Clinical and virological aspects107
Serum ferritin as an independent risk factor for severity in COVID-19 patients105
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review105
Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients105
Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19101
Excess mortality due to COVID-19 in Germany95
Post-COVID-19 functional status six-months after hospitalization94
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers92
Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis92
Effects of age and sex on recovery from COVID-19: Analysis of 5769 Israeli patients91
Impact of non-pharmaceutical interventions targeted at COVID-19 pandemic on influenza burden – a systematic review90
Clinical features and outcomes of pregnant women suspected of coronavirus disease 201989
Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection86
Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load85
Antibody titers and protection against a SARS-CoV-2 infection83
The lung tissue microbiota features of 20 deceased patients with COVID-1983
Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge82
Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups82
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection82
0.045397043228149